FDA supports experimental epilepsy drug made from marijuana plant compound

An experimental medication that could become the first drug derived from a marijuana plant approved in the US, received a boost from Food and Drug Administration (FDA) staff. The treatment’s maker, UK company GW Pharmaceuticals, provided “substantial evidence” of the drug’s effectiveness, FDA …

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.